Coral Labs.

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE683E01017
  • NSEID:
  • BSEID: 524506
INR
394.90
11.9 (3.11%)
BSENSE

Apr 02

BSE+NSE Vol: 5.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024

Compare Profit and Loss Results of Coral Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
115.00
473.00
-358.00
-75.69%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
115.00
473.00
-358.00
-75.69%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-10.00
13.00
130.00%
Raw Materials Consumed
49.00
472.00
-423.00
-89.62%
Power & Fuel Cost
3.00
0.00
3.00
0%
Employee Cost
14.00
0.00
14.00
0%
Operating Expenses
4.00
1.00
3.00
300.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
3.00
-1.00
-33.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
5.00
0.00
5.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
88.00
471.00
-383.00
-81.32%
Operating Profit (PBDIT) excl Other Income
26.00
2.00
24.00
1,200.00%
Other Income
9.00
9.00
0.00
0.00%
Operating Profit (PBDIT)
35.00
12.00
23.00
191.67%
Interest
0.00
4.00
-4.00
-100.00%
Profit before Depriciation and Tax
35.00
8.00
27.00
337.50%
Depreciation
2.00
1.00
1.00
100.00%
Profit Before Taxation & Exceptional Items
33.00
6.00
27.00
450.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
32.00
6.00
26.00
433.33%
Provision for Tax
8.00
2.00
6.00
300.00%
Profit After Tax
24.00
4.00
20.00
500.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
147.00
53.00
94.00
177.36%
Profit Available for appropriations
171.00
57.00
114.00
200.00%
Appropriations
171.00
57.00
114.00
200.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
67.61
1.42
66.19
4,661.27%
Profit And Loss - Net Sales
Net Sales 115.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 37.47% vs 7.09% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 26.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 61.58% vs 326.03% in Mar 2024

Profit And Loss - Interest
Interest 0.10 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48,700.00% vs -99.94% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 24.16 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 52.99% vs 144.97% in Mar 2024